Moniek A. De Witte

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Chronic graft-versus-host disease: Current situation and unmet needs - A European position statement.

Chronic graft-versus-host disease: Current situation and unmet needs - A European position statement.

Journal: Bone marrow transplantation

Published: December 24, 2025

Posttransplant cells for the win? DLI and adoptive cell therapy to eradicate MRD.

Posttransplant cells for the win? DLI and adoptive cell therapy to eradicate MRD.

Journal: Hematology. American Society of Hematology. Education Program

Published: December 05, 2025

Overexpression of the TGF-β target CCN2 in megakaryocytes: a common feature of MDS with mutated SF3B1 : Uncovering novelinsights into the bone marrow microenvironment in MDS.

Overexpression of the TGF-β target CCN2 in megakaryocytes: a common feature of MDS with mutated SF3B1 : Uncovering novelinsights into the bone marrow microenvironment in MDS.

Journal: Virchows Archiv : an international journal of pathology

Published: November 24, 2025

Decreased Chronic GvHD With Post-Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor: A Study From the Chronic Malignancies Working Party of the EBMT.

Decreased Chronic GvHD With Post-Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor: A Study From the Chronic Malignancies Working Party of the EBMT.

Journal: American journal of hematology

Published: October 10, 2025

A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm.

A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm.

Journal: Bone marrow transplantation

Published: September 05, 2025

Preserved measles immunity after allogeneic hematopoietic stem cell transplantation in a cohort of mainly αβ T-cell-depleted graft recipients.

Preserved measles immunity after allogeneic hematopoietic stem cell transplantation in a cohort of mainly αβ T-cell-depleted graft recipients.

Journal: Bone marrow transplantation

Published: July 22, 2025

Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor-1 Receptor (CSF1R)-Related Disorder.

Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor-1 Receptor (CSF1R)-Related Disorder.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: April 18, 2025

αβT/CD19-depleted Allogeneic Stem Cell Transplantation in Adults with Inborn Errors of Immunity.

αβT/CD19-depleted Allogeneic Stem Cell Transplantation in Adults with Inborn Errors of Immunity.

Journal: Journal of clinical immunology

Published: April 15, 2025

Pure white cell aplasia following allogeneic hematopoietic stem cell transplantation.

Pure white cell aplasia following allogeneic hematopoietic stem cell transplantation.

Journal: Bone marrow transplantation

Published: April 14, 2025

The role of psychosocial adjustment in the quality of life of patients with myeloproliferative neoplasms.

The role of psychosocial adjustment in the quality of life of patients with myeloproliferative neoplasms.

Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society

Published: December 18, 2024

Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT.

Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT.

Journal: Bone marrow transplantation

Published: October 30, 2024

Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis.

Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis.

Journal: Blood

Published: October 15, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026